Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Nov;47(11):e70044.
doi: 10.1002/clc.70044.

Obesity Paradox and the Effect of NT-proBNP on All-Cause and Cause-Specific Mortality

Rupinder Kaur Bahniwal  1 , Nargiza Sadr  1 , Colleen Schinderle  1 , Cynthia J Avila  2 , Julie Sill  1 , Rehan Qayyum  1
Affiliations
Multicenter Study

Obesity Paradox and the Effect of NT-proBNP on All-Cause and Cause-Specific Mortality

Rupinder Kaur Bahniwal et al. Clin Cardiol. 2024 Nov.

Abstract

Background: In heart failure patients, obesity is associated with better outcomes as compared to normal weight, a phenomenon called the obesity paradox.

Objective: To examine if obesity modifies the relationship between NT-proBNP and all-cause and cause-specific mortality in adults without coronary artery disease or heart failure history.

Methods: We used the National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2004 and linked it with mortality through December 31, 2019. Participants > 18 years were categorized into normal weight (BMI ≤ 25 kg/m2), overweight (BMI > 25-29.9 kg/m2) and obese (BMI > 29.9 kg/m2). NT-proBNP levels were categorized as low (< 126 pg/mL) or high (≥ 126 pg/mL). Using Cox proportional hazard models, we examined effect modification by obesity using interaction, without and with adjusting for potential confounders.

Results: Of the 12 621 participants, 2794 (22%) died during 202 859 person-years follow-up. In adjusted models, normal-weight participants with high NT-proBNP had 2 times higher all-cause mortality risk than those with low NT-proBNP (HR = 2.05; 95%CI = 1.74, 2.41; p < 0.001); however, this mortality risk was 27% lower in obese participants (HR interaction = 0.73; 95%CI = 0.59, 0.92; p = 0.008). Similarly, in normal-weight participants, the difference in other-cause mortality risk between high and low NT-proBNP participants was significant in adjusted models (HR = 2.27; 95%CI = 1.81, 2.85; p < 0.001) and obese participants had 48% lower other-cause mortality risk between those with high and low NT-proBNP (interaction HR = 0.52; 95%CI = 0.36, 0.77; p = 0.001). Conversely, obesity did not modify the relationship between NT-proBNP and cardiovascular or cancer mortality.

Conclusions: In patients free of heart failure or coronary artery disease, obesity may be protective against mortality associated with high NT-proBNP.

Keywords: NT‐proBNP; healthy population; mortality; obesity paradox.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect modification by weight categories of the relationship between NT‐proBNP and all‐cause mortality and cause‐specific mortality. Survey‐weighted unadjusted Cox proportional hazard model comparing low (< 126 pg/mL) and high (≥ 126 pg/mL) NT‐proBNP levels. Weight categories were normal weight (BMI < 25 kg/m2) overweight (25 to < 30 kg/m2), and obesity (≥ 30 kg/m2). In the absence of obesity paradox, we would expect to see both lines parallel and the difference between the two lines to be not statistically significant.
See this image and copyright information in PMC

References

    1. Gruberg L., Weissman N. J., Waksman R., et al., “The Impact of Obesity on the Short‐Term and Long‐Term Outcomes After Percutaneous Coronary Intervention: the Obesity Paradox?,” Journal of the American College of Cardiology 39, no. 4 (2002): 578–584. - PubMed
    1. Tutor A. W., Lavie C. J., Kachur S., Milani R. V., and Ventura H. O., “Updates on Obesity and the Obesity Paradox in Cardiovascular Diseases,” Progress in Cardiovascular Diseases 78 (2023): 2–10. - PubMed
    1. Alebna P. L., Mehta A., Yehya A., daSilva‐deAbreu A., Lavie C. J., and Carbone S., “Update on Obesity, the Obesity Paradox, and Obesity Management in Heart Failure,” Progress in Cardiovascular Diseases 82 (2024): 34–42. - PubMed
    1. Greenlee H., Unger J. M., LeBlanc M., Ramsey S., and Hershman D. L., “Association Between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials,” Cancer Epidemiology, Biomarkers & Prevention 26, no. 1 (2017): 21–29. - PMC - PubMed
    1. Bozkurt B., Coats A. J. S., Tsutsui H., et al., “Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association,” European Journal Of Heart Failure 23, no. 3 (2021): 352–380. - PubMed

Publication types

MeSH terms

LinkOut - more resources